
06 Sep 2016
PANMURE: Revised estimates and continuing clinical progress
This content is only available within our institutional offering.

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
PANMURE: Revised estimates and continuing clinical progress
Faron Pharmaceuticals Oy (FARN:LON) | 200 5 1.3% | Mkt Cap: 223.9m
- Published:
06 Sep 2016 -
Author:
Dr Julie Simmonds -
Pages:
7 -